Ferré F, Martin P, Lagrou C, Raes M B, Ghysdael J, Saule S, Stéhelin D
INSERM Unité 186/CNRS UA 04 1160, Institut Pasteur, Lille, France.
Oncogene. 1987;1(4):387-93.
We investigated the coding capacity of the previously reported open reading frame (ORF) of the human c-myc exon 1. By in vitro translation assay, we found that exon 1 ORF was translated into a 20-kd protein (p20 protein). In order to obtain antisera raised against the p20 protein, we constructed a plasmid vector which expressed most of the exon 1 ORF as a 25-kd (P25) protein in Escherichia coli. Polyclonal antisera raised against this P25 protein specifically precipitated a chimeric protein which contained exon 1-related amino acid sequences. We used these antisera to test for the existence of an exon 1 product in human cells. In the human cell lines tested, these antisera have failed so far to detect any exon 1-related proteins. However, exon 1-related proteins were detected with the anti-p20 antisera in quail embryonic cells (QEC) transfected by human c-myc recombinants constructed to express such proteins, but were expressed at low levels compared with the human c-myc protein also expressed in the transfected QEC. Our results suggest that secondary structure of the mRNA could be responsible for the low expression of the exon 1 product in QEC.